HARVARD BIOSCIENCE, INC. Other Noncash Income (Expense)
HARVARD BIOSCIENCE, INC. (HBIO) reported Other Noncash Income (Expense) of $53.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2021-05-07
- HARVARD BIOSCIENCE, INC. other noncash income (expense) for the quarter ending 2021-03-31 was $53.00K, a 67.28% decline year-over-year.
- HARVARD BIOSCIENCE, INC. other noncash income (expense) for the quarter ending 2020-12-31 was -$98.00K.
- HARVARD BIOSCIENCE, INC. other noncash income (expense) for the quarter ending 2020-09-30 was $414.00K.
- HARVARD BIOSCIENCE, INC. other noncash income (expense) for the quarter ending 2020-06-30 was -$581.00K.
- HARVARD BIOSCIENCE, INC. other noncash income (expense) for fiscal 2020 was -$103.00K.
- HARVARD BIOSCIENCE, INC. other noncash income (expense) for fiscal 2019 was -$188.00K.
- HARVARD BIOSCIENCE, INC. other noncash income (expense) for fiscal 2018 was -$25.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | $53.00K 10-Q · filed 2021-05-07 | -$45.00K derived: sum of 2 quarters · filed 2021-05-07 | $369.00K derived: sum of 3 quarters · filed 2021-05-07 | -$212.00K derived: sum of 4 quarters · filed 2021-05-07 | |
| 2020-12-31 | -$98.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | $316.00K derived: sum of 2 quarters · filed 2021-03-17 | -$265.00K derived: sum of 3 quarters · filed 2021-03-17 | -$103.00K 10-K/A · filed 2021-03-17 | |
| 2020-09-30 | $414.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$167.00K derived: sum of 2 quarters · filed 2020-11-06 | -$5.00K 10-Q · filed 2020-11-06 | -$152.00K derived: sum of 4 quarters · filed 2021-05-07 | |
| 2020-06-30 | -$581.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$419.00K 10-Q · filed 2020-08-10 | -$566.00K derived: sum of 3 quarters · filed 2021-05-07 | -$598.00K derived: sum of 4 quarters · filed 2021-05-07 | |
| 2020-03-31 | $162.00K 10-Q · filed 2021-05-07 | $166.00K 10-Q · filed 2020-05-08 | $15.00K derived: sum of 2 quarters · filed 2021-05-07 | -$17.00K derived: sum of 3 quarters · filed 2021-05-07 | -$22.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | -$147.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | -$179.00K derived: sum of 2 quarters · filed 2021-03-17 | -$184.00K derived: sum of 3 quarters · filed 2021-03-17 | -$188.00K 10-K/A · filed 2021-03-17 | |
| 2019-09-30 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$37.00K derived: sum of 2 quarters · filed 2020-11-06 | -$41.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$9.00K 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | -$4.00K 10-Q · filed 2020-05-08 | ||||
| 2018-12-31 | -$25.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |